Lumenis announced the launch of OptiLIFT, a new, proprietary Dynamic Muscle Stimulation technology (DMSt) for toning facial muscles to address lower lid laxity and impaired blinking without the need for surgery. OptiLIFT is now available in the United States, with other markets expected to follow, the company said in a press release. 

OptiLIFT utilizes DMSt to restore muscle tone, resulting in improved function of the lower eyelid and blinking quality. In a new clinical study, led by James Chelnis, MD, FACS, an ophthalmic plastic and reconstructive surgeon at Manhattan Face & Eye, Lumenis’s DMSt demonstrated a reduction in lid laxity by at least 75%, an improvement in blinking quality by at least 70%, and a 286% increase in tear break-up time, Lumenis said in the press release.

Specifically designed for treatment of the periorbital area, OptiLIFT’s DMSt works by activating the facial muscles with electrical impulses, tightening and toning the periorbital muscle. It also features a radiofrequency component that precisely delivers heat to skin layers to enhance collagen formation. According to the company, OptiLIFT is also available with an optional RF microneedling upgrade, which utilizes ultra thin needles and a double RF mechanism to increase skin smoothness.

Lumenis said it will be exhibiting OptiLIFT (at booth #F1829) at the upcoming Vision Expo East in Orlando, Florida.